Page 106

Marzo 2016

ARTÍCULO ESPECIAL tries-2015-background. (Consultado el 1 de marzo de 2016). 25. Adebamowo C, Bah-Sow O, Binka F, Bruzzone R, Caplan 376 A, Delfraissy JF, et al. Randomised controlled trials for Ebola: practical and ethical issues. Lancet 2014; 384 (9952): 1423-4. 26. Nuffield Council on Bioethics. Briefing Note. Zika: ethical considerations. 9 Feb. 2016. Disponible en: http:// nuffieldbioethics.org/wp-content/uploads/NCOB-briefing note-zika-ethical-considerations.pdf. 27. Lanini S, Zumla A, Ioannidis JP, Di Caro A, Krishna Ética y Ébola - J. P. Beca et al S, Gostin L, et al. Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? Lancet Infect Dis 2015; 15: 738-45. 28. Basarab M, Bowman C, Aarons EJ, Cropley I. Zika virus. BMJ. 2016 Feb 26; 352:i1049. doi: 10.1136/bmj.i1049. 29. Moon S, Sridhar D, Pate MA, Jha AK, Clinton C, Delaunay S, et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. Lancet 2015; 386: 2204-21. Rev Med Chile 2016; 144: 371-376


Marzo 2016
To see the actual publication please follow the link above